Skip to main
We’re doing some system maintenance
  1. /
  2. Stocks
  3. /
  4. IGM Biosciences Inc
IGMS

Buy IGMS Stock

IGMS
See IGMS stock price and Buy/Sell IGM Biosciences Inc with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
IGMS

IGM Biosciences Inc (IGMS)

About IGM Biosciences Inc (IGMS)

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies. The firm’s product pipeline includes IGM-2323, which is a CD20 x CD3 bispecific IgM antibody designed to treat patients with ...Read more
Market Cap
$819.02M
1 Year High
$76.20
Volume
108.51k
1 Year Low
$12.67
Price to Earnings Ratio
Open
$19.20
Dividend Rate
High
$19.95
Dividend Yield
Low
$18.70

Community

People who own or watch IGMS stock

IGMS Price Targets

What analysts think IGMS stock price will be.
$18.76
$42.80
128.1% Upside
$12$81

IGMS Stock Rating

What analysts recommend for IGMS stock, on a scale from 1(buy) to 5(sell).
Buy1.5 / 5
BuyHoldSell

IGMS Stock Earnings

The value each IGMS share was expected to gain vs. the value that each IGMS share actually gained.
Expected
Actual

IGMS Stock News

Frequently Asked Questions (FAQ)

As of Sep 26, 2022, the market cap for IGMS stock is $819.02M

The 52-week high for IGMS stock is $76.20. The current IGMS stock price $18.76 is 75.38% below its 52-week high

The 52-week low for IGMS stock is $12.67. The current IGMS stock price $18.76 has increased 32.46% from its 52-week low

No, the IGMS stock does not pay dividends to its shareholders

The target price for IGMS stock is $42.80 based on the average of what a group of analyst think IGMS stock could be worth at a future date. This is not a prediction by Public.com

Buy IGMS Stock

IGMS
See IGMS stock price and Buy/Sell IGM Biosciences Inc with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch IGMS stock
  • MelanieN avatar
  • RxSeun avatar
  • opyekongozob avatar
  • blawgames avatar
  • katjer1992 avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.